Antioxidant molecules reduce oxidative stress and protect cells from reactive oxygen species (ROS)-mediated cellular damage and probably the development of cancer. We have investigated the contribution of X-box-binding protein (XBP1), a major endoplasmic reticulum stress-linked transcriptional factor, to cellular resistance to oxidative stress. After exposure to hydrogen peroxide (H 2 O 2 ) or a strong ROS inducer parthenolide, loss of mitochondrial membrane potential (MMP) and subsequent cell death occurred more extensively in XBP1-deficient cells than wild-type mouse embryonic fibroblast cells, whereas two other anticancer agents induced death similarly in both cells. In XBP1-deficient cells, H 2 O 2 exposure induced more extensive ROS generation and prolonged p38 phosphorylation, and expression of several antioxidant molecules including catalase was lower. Knockdown of XBP1 decreased catalase expression, enhanced ROS generation and MMP loss after H 2 O 2 exposure, but extrinsic catalase supply rescued them. Overexpression of XBP1 recovered catalase expression in XBP1-deficient cells and diminished ROS generation after H 2 O 2 exposure. Mutation analysis of the catalase promoter region suggests a pivotal role of CCAAT boxes, NF-Y-binding sites, for the XBP1-mediated enhancing effect. Taken together, these results indicate a protective role of XBP1 against oxidative stress, and its positive regulation of catalase expression may at least in part account for this function.
High levels of reactive oxygen species (ROS) damage cells and are believed to be associated with various human pathologies, including aging, carcinogenesis and neurodegenerative disorders. [1] [2] [3] To minimize the damage, hosts evolve non-enzymatic and enzymatic antioxidant defenses, the latter include catalase, superoxide dismutases (SODs) and glutathione peroxidases (GPxs). Catalase catalyzes hydrogen peroxide decomposition and has a central role in defense against oxidants generated through various metabolic pathways. 4 Catalase activity is high in the liver but is also found in the kidney and erythrocytes. 5 Catalase also plays a crucial role in hematopoietic renewal cells, and maintains bone marrow stem cells. 6 We recently reported that its expression level in multiple myeloma cells is a pivotal factor determining sensitivity to parthenolide (PTL), 7 which strongly induces ROS and is a candidate anticancer agent against myeloid leukemia cells. 8 Catalase gene expression is mainly regulated by CCAAT/enhancer-binding protein-b (C/EBP-b), 9 which is a member of the basic region/leucine zipper (bZIP) family of transcription factors, and/or by nuclear factor Y (NF-Y), which directly binds to the CCAAT boxes. 10 In addition, SOD1 gene expression is known to be regulated by C/EBP-b, and human phospholipid hydroperoxide GPx is regulated by both C/EBP-e and NF-Y. 11, 12 Thus, the CCAATbinding proteins 13 appear to be crucial for the regulation of their basal transcription.
The transcriptional factor X-box-binding protein 1 (XBP1) belongs to the bZIP family and is activated by accumulating unfolded proteins and other endoplasmic reticulum (ER) stress factors. 14, 15 Upon ER stress, XBP1 mRNA is spliced and creates a translational frame shift. 16 The spliced XBP1 regulates a subset of ER-resident chaperone genes in the unfold protein response and protects cells from ER stress. 17, 18 XBP1 is widely expressed in adult tissues, and essential for hepatogenesis, cardiac myogenesis and plasma cell differentiation. [19] [20] [21] A recent gene profiling study identified many genes as direct targets of XBP1 and their expression is regulated in a distinct cell type-or condition-dependent manner. 22 Importantly, the targets include a set of genes linked to DNA damage and repair pathways as well as redox homeostasis and oxidative stress responses. In addition, XBP1 is essential for survival during hypoxia. 23 These accumulating data suggest that XBP1 governs a variety of biological activities.
There are conflicting results regarding XBP1 functions in several types of stress. XBP1 overexpression confers resistance to growth factor deprivation and enhances proliferation independently of growth factors, 24, 25 whereas XBP1 knockdown induces resistance to several ER stresses. 26, 27 Thus, the precise functions of XBP1 remain obscure. As described above, some target genes of XBP1 are classified in categories unrelated to processes associated with ER function. One of the unexpected categories includes genes involved in redox homeostasis and oxidative stress responses, 22 which strongly suggests that XBP1 protects cells from oxidative stress, but to our knowledge there are few studies of this possibility. In this study, we investigated a possible role of XBP1 in sensitivity to oxidative stress. We found that disruption of XBP1 enhanced sensitivity to oxidative stress, that is, it augmented ROS generation and persistent p38 phosphorylation. Interestingly, we found that XBP1 deletion or knockdown decreased expression of several antioxidant genes, including catalase, SOD1 and TRX1. Our results suggest a novel protective function for XBP1 against oxidative stress, probably, at least in part, through positive regulation of catalase expression.
Results
Loss of XBP1 enhances sensitivity to H 2 O 2 . To explore a role for XBP1 in cell survival under oxidative stress, we investigated the effects of H 2 O 2 on the viability of XBP1 wildtype and XBP1-deficient mouse embryonic fibroblasts (MEFs). At 24 h after H 2 O 2 exposure, cell survival was decreased in a dose-dependent manner, and 1 mM H 2 O 2 exposure substantially decreased cell viability (approximately 58%) in XBP1-deficient cells, whereas only 12% of the wildtype cells lost their viability (Figure 1a) . Pretreatment with the free radical scavenger L-N-acetylcystein (L-NAC) clearly decreased H 2 O 2 -induced cell death in both MEF cells (Figure 1b ). The enhanced sensitivity to H 2 O 2 was also exhibited by an increased loss of mitochondrial membrane potential (MMP), and this loss was almost completely inhibited by L-NAC (Figure 1c ), indicating that under oxidative stress, more extensive mitochondrial damage occurred in XBP1-deficient cells.
Loss of XBP1 specifically enhances sensitivity to oxidative stress. The sesquiterpene lactone, parthenolide (PTL), the principal active component in feverfew (Tanacetum parthenium) used for fever, migraine and arthritis, induces intracellular oxidative stress, which is manifested by elevated ROS levels. 7, 8 Similar to H 2 O 2 , PTL substantially decreased cell viability in XBP1-deficient cells, but had much less of an effect in XBP1 wild-type cells (Figure 2a ), whereas two different types of anticancer agents VP16 (topoisomerase II inhibitor) and FK228 (HDAC inhibitor) induced cell death similarly in both MEF cells. PTL-induced cell death was almost completely blocked by L-NAC (Figure 2b ). In XBP1-deficient cells, more extensive loss of MMP occurred, but similar levels of MMP disruption were observed with VP16 or FK228 (Figure 2c (Figure 2c ), but L-NAC had little effect on VP16-or FK228-induced MMP disruption (data not shown). These results strongly suggest that disruption of XBP1 specifically enhances sensitivity to oxidative stress.
Enhanced ROS generation in XBP1-deficient cells. To determine the molecular mechanism for the XBP1-mediated protective effect on oxidative stress, we first monitored ROS generation after H 2 O 2 exposure in both MEFs. XBP1-deficient cells showed more extensive increases of ROS levels after H 2 O 2 treatment (Figure 3a) . PTL also induced greater ROS generation in XBP1-deficient MEF cells, an effect which was almost completely canceled by L-NAC pretreatment. Exposure to H 2 O 2 or PTL induced prolonged phosphorylation of p38 and/or c-Jun N-terminal kinase JNK in XBP1-deficient cells (Figure 3b ). The prolonged phosphorylation of p38 was almost completely inhibited by L-NAC pretreatment (Figure 3c ). These data strongly suggest that XBP1 deficiency in MEF cells impairs their antioxidant ability. We next investigated whether spliced XBP1 affected expression levels of these genes. Thapsigargin clearly induced XBP1 splicing and activated its downstream signals, that is, induction of IPK mRNA; however, expressions of catalase, SOD1 and TRX1 mRNA were not increased, but rather decreased (Figure 4g ), suggesting that the spliced form of XBP1, XBP1(S) may be unable to positively regulate the expression of these antioxidant genes.
We further investigated the possible linkage of XBP1 to expression of these antioxidant genes in vivo. Steady-state level of XBP1 mRNA expression was highest in the murine liver and kidney, and exhibited a similar pattern to the expression of catalase, but SOD1 and TRX1 mRNAs were more broadly expressed (Figure 5a ). Indeed, catalase protein expression was highest in the liver, and lowest in the spleen in TRX1 mRNA as observed in XBP1-deficient cells, whereas GPX, OGG1 and NOX2 mRNA expression levels were unchanged ( Figure 6a ). In contrast, random-siRNA neither decreased catalase, SOD1 nor TRX1 mRNA expression. Nor were expression levels of apoptosis-related molecules Bid, BAX and Bcl-xL altered by XBP1 knockdown. (Figure 6a ). Moreover, knockdown of another ER stress mediator PERK did not affect catalase transcripts (Figure 6c ), whereas XBP1 knockdown decreased catalase transcripts (approximately two-fold) assessed by real-time PCR (Figure 6d ). These data suggest that catalase, probably SOD1 and TRX1, is regulated downstream to an XBP1-mediated pathway. Importantly, XBP1 knockdown actually decreased catalase protein levels, and more strongly elevated ROS generation Although a previous study showed that the pGL3-Enhancer CAT(À191/ þ 68) reporter construct had the highest promoter activity in the murine myoblast cells, 10 the construct showed the lowest luciferase activity in the XBP1-deficient cells, and XBP1(U) significantly rescued the activity (Figure 7c ), demonstrating that XBP1 actually activates catalase gene expression, and suggesting that XBP1-mediated regulatory elements may be located between À191 to þ 68. The XBP1(U)-mediated enhancing effect was not observed in XBP1 wild-type MEF, and oxidative stress did not affect catalase transcription (Figure 7d) , confirming the data shown in Figure 4b .
This region contains no distinct XBP1-binding sites, but has several potential transcriptional factor-binding sites. Previous studies indicate that three CCAAT boxes are considered crucial for catalase transcription, and among them, the second CCAAT box plays a pivotal role for NF-Y binding and its promoter activity. 9, 10 In our study, XBP1(U) overexpression clearly enhanced the luciferase activity from pGL3-Basic CAT(À191/ þ 68), but much less from the construct carrying the mutation at the second CCAAT box, and almost completely lost its enhancing effect from that carrying mutations at the second and third CCAAT boxes (Figure 7e ). In contrast, mutation at the second GC box exhibited much less effect on the enhancing effect of XBP1(U). These results suggest a requirement of CCAAT box-mediated signals for the effect.
XBP1 and nuclear factors binding to catalase promoter. To explore the mechanism for XBP1-mediated enhancing effect on catalase transcription, gel shift assays were performed using the catalase promoter probe (À186/ À32), which contains all potential transcription factor-binding sites except the third GC box. 10 Nuclear extracts from both MEFs exhibited a similar pattern of multiple shifted bands, but those from XBP1-deficient cells substantially decreased their intensity (Figure 8a) . Importantly, the XBP1(U)-rescued cells enhanced the intensity of the largest band, although these nuclear extracts exhibited a similar intensity of shifted bands with the AP2 consensus oligonucleotide probe ( Figure  8a and b) . Moreover, XBP1(U) overexpression neither affected expression nor intracellular localization of NF-YA, NF-YB and CEBP-b (Figure 8c ). Immunoprecipitation assay showed that the catalase promoter DNA-protein complexes actually contain NF-YA, and their interaction appeared to be (Figure 8d ). In addition, the mutation at the second CCAAT box substantially decreased their DNAprotein complex formation and impaired the enhancing effect of XBP1 overexpression, supporting a crucial role of NF-Y complex for XBP1-mediated catalase transcription.
Discussion
Our results show that XBP1 actually protects cells from oxidative stress. Although several antioxidant genes have been identified as direct targets of XBP1, our experiments are the first to show its functional linkage to oxidative stress. Oxidative stress, H 2 O 2 or PTL, induced greater ROS generation and persistent p38 phosphorylation in XBP1-deficient cells implying that loss of XBP1 functions may impair cellular redox homeostasis. To explore how XBP1 functions link to antioxidant activity, we compared expression levels of phase II detoxification enzymes and other antioxidant proteins between XBP1-deficient and wild-type MEFs. We found distinct decreases of antioxidant gene expressions in XBP1-deficient cells, such as catalase, SOD1 as well as TRX1, but no alteration in GPx, OGG1 and NOX2 expression. As catalase, SOD1 and TRX1 are not direct targets of XBP1, XBP1 probably regulates these genes indirectly.
Among antioxidant genes, catalase appears to be primarily crucial, as its expression is tightly linked to XBP1 expression in vivo ( Figure 5 ) and its promoter has CCAAT boxes, targets of NF-Y, 10 which cooperatively functions with XBP1. Namely, XBP1 can activate transcription of target genes carrying the ER stress response element (ERSE) (CCACG) fully when NF-Y binds to the CCAAT part of the ERSE, 16, 22 indicating their tight functional association in ERSE-mediated pathway. Our study showed that mutations at two CCAAT boxes strongly impaired enhancing effects of XBP1 on catalase expression (Figure 7 ). In addition, gel shift and immunoprecipitation studies showed that in XBP1-deficient cells, XBP1 overexpression enhanced binding of NF-YA to catalase promoter region, but this enhancement was not detected when the catalase promoter carries a mutation at the second CCAAT box (Figure 8 ). These data suggest that as observed in ERSEmediated pathway, antioxidant activity of XBP1 may also be linked to CCAAT box-mediated signals, probably through NF-Y complexes. As there is no distinct binding site of XBP1 at the catalase promoter region, and no distinct effect of XBP1 on NF-YA and NF-YB expression levels, it remains largely unknown how XBP1 can regulate NF-Y/catalase promoter complex formation. In addition, we cannot exclude a possibility that XBP1 may inhibit some silencers and activate catalase gene independently of CCAAT box-mediated pathway.
In general, XBP1 is activated in response to ER stress. Our data indicate that XBP1 also functions against oxidative stress. Currently, there are many molecules known to be involved in both stress signals, Heme oxygenase (HO-1) is strongly induced by oxidative stress, and also by ER stress, [28] [29] [30] whereas stress kinases, the MAP kinase family members p38 and JNK are simultaneously activated by both types of stress. 31, 32 In addition, the ER stress-inducible transcription factor ATF4 induces a variety of genes for amino-acid import and for protection from oxidative stress. 33 Thus, accumulating evidence strongly suggests that both stress signals are tightly inter-related. Considering that ROS induce lipid peroxidation and lead to membrane damage in the mitochondria, lysosome and ER organelle, 34 simultaneous activation of both ER and oxidative stress responses is rational to maintain viability. In this context, our data enlighten XBP1 as a key molecule governing these stress responses.
XBP1 mRNA is spliced under ER stress and spliced XBP1, XBP1(S), is an active transcription factor. 16 We showed that an ER stress inducer thapsigargin failed to activate catalase transcripts but rather decreased them, although XBP1 splicing clearly occurred (Figure 4 ). This suggests that although XBP1(U) may be sufficient to positively regulate the expression of catalase, XBP1(S) is inactive. Indeed, overexpression of XBP1(U) strongly increased catalase expression, but XBP1(S) failed (Figure 7) . Importantly, reporter and gel shift assays suggest that XBP1(U)-mediated enhancing effect on catalase transcription depends upon CCAAT boxes crucial for NF-Y binding (Figures 7 and 8) .
Considering that NF-Y is necessary for full activation of ERSE, 16, 22 but IRE activation is not essential, 35 XBP1 activation is not necessary in this pathway, either. These data strongly suggest a unique function of XBP1(U) independent of XBP1(S), although previous reports suggest an inhibitory function of XBP1(U) on XBP1(S) through rapid degradation. 36, 37 Obviously, we do not fully understand their precise biological activities.
XBP1 is essential for survival under hypoxic conditions, and positively regulates tumor growth. [23] [24] [25] This knowledge indicates that XBP1 may have multiple functions against a variety of stresses, an important possibility in cancer cell biology. Considering the process of tumor invasion or metastasis, cancer cells should survive under insufficient ATP, oxygen and nutrition. Consequently, XBP1 overexpression may confer metastatic potential on cancer cells. Indeed, breast cancer cells MCF-1 and T47D stably and abundantly express an active form of XBP1 and no longer require estrogen for cell growth., 24, 25 In this context, XBP1 would be a good candidate as a molecular target for the prevention of cancer metastasis. Conversely, increased XBP1 expression may contribute to a reduction of oxidative stress and prevention of aging. Beyond question, further studies to define XBP1 functions in oxidative stress are essential. ROS detection. Following treatment, cells were incubated with 10 mM 5-(and-6)-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (carboxy-H 2 DCFDA) C-400 (Molecular Probes, Eugene, OR, USA) for 30 min, after which they were washed, and further incubated with complete medium for 2-3 h. ROS generation was determined using a FACScan flow cytometry using CellQuest Softwaret and fluorescent signals were displayed as histograms.
Detection of mitochondrial membrane potential (Dwm). Following treatment, cells were incubated with DePsipher solution (Trevigen, Gaithersburg, MD, USA) for 20 min, after which they were washed with PBS, resuspended with reaction buffer, Dcm was immediately determined using a FACScan flow cytometer (Becton Dickinson, Mountain View, CA, USA). DePsipher is a lipophilic cation, which aggregates upon membrane polarization and forms an orange-red fluorescent compound. MMP disruption blocks aggregation of DePsipher, which reverts to its green monomeric green fluorescent form. Thus, a decrease of the fluorescent signals (FL2) indicates loss of MMP.
Western blotting. After washing with ice-cold PBS, cells were lysed by adding 200 ml of RIPA buffer (100 mM NaCl, 2 mM EDTA, 1 mM PMSF, 1% NP-40 and 50 mM Tris-HCl (pH 7.2)). Total cell lysates were collected and their protein concentration was evaluated using a protein assay (Bio-Rad, Melville, NY, USA). The lysates (20 mg per lane) were separated by 10-15% SDS-PAGE gels and then transferred to PVDF membranes (Millipore, Bedford, MA, USA) at 20 V for 50 min. Membranes were soaked in 5% bovine serum albumin (Sigma) overnight. The membranes were incubated with primary antibodies overnight at 41C, and thereafter incubated with the corresponding peroxidase-linked secondary antibodies (Amersham or MBL) for 1 h at room temperature. Signals were developed by a standard enhanced chemiluminescence method following the manufacturer's protocol (Amersham).
Reverse transcriptase-PCR and transfection. Total RNA of HeLa or MEF cells was extracted with TRIzol (BRL Life and Technologies, MD, USA). The indicated cDNAs were amplified from 2 mg of total RNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) with random primers. The cDNA products were analyzed on 2% agarose gel and confirmed by nucleotide sequencing. The following primer pairs were used for RT-PCR Small RNA interference. The 21-nt duplex small interfering (si) RNA pools for catalase (siGENOME SMARTpool M-010021), and control siRNAs (random; 5 0 -NNACTCTATCTGCACGCTGAC-3 0 ) were purchased from Dharmacon (Lafayette, CO, USA). The siRNA for XBP1-or PKR-like ER kinase PERK (Stealth RNAi) was from Invitrogen. Cells (5 Â 10 5 cells per well in a 12-well plate) were incubated for 24 h, and transfected twice or four times with XBP1 siRNA, catalase siRNA, PERK siRNA or control random siRNA (siRandom) duplexes (80 nmol each) using Lipofectamine RNAiMAX (Invitrogen). After 4-7 days, cells were used for the analysis for western blots and cell viability. Transfection efficiency (usually 450%) was assessed in parallel wells by transfection with pEGFP expression vector (BD Biosciences Clontech, Mountain View, CA, USA).
XBP1 overexpression. XBP1-deficient cells were transfected with XBP1 expression vectors, 38 that is, an unspliced form of XBP1, XBP1(U), a stable XBP1(U), XBP1(KKK), or a spliced from of XBP1, XBP1(S) using the Lipofectamine LTX Transfection Reagent (Invitrogen). At 7-10 days after repeated transfection (2 or 3 times), cells were harvested for western bots and RT-PCR as well as for the detection of ROS generation.
Catalase reporter assays. As described previously, 39 XBP1-deficient cells were transiently transfected with a pRL-TK reporter plasmid (Promega Corp.) and luciferase reporter plasmids containing mouse catalase 5 0 flanking region, 10 that is, the pGL3-Enhancer (À1394/ þ 68), (À191/ þ 68), pGL3-Basic CAT(À191/ þ 68) and its mutants using the Lipofectamine LTX Transfection Reagent. The mutations are located at the second CCAAT box, the second and third CCAAT boxes, and the second GC box. Catalase transcription was measured as luciferase activity using a luminometer (Mini Lumat LB 9506) 48 h after transfection and normalized to Renilla luciferase activity. To detect the effect of XBP1 on catalase transcription, either the XBP1(U) expression vector or its vehicle was co-transfected.
Electrophoretic mobility shift assays. Mobility shift assay was performed using the gel shift assay kit (Promega Corp.). The catalase promoter probe as described below and the AP2 probe (Promega Corp.) were end-labeled with [g-32 P]ATP (3000 Ci/mmol). The indicated nuclear extracts (5 mg) were prepared using the CelLytict NuCLEARt Extraction Kit (Sigma) according to the manufacturer's protocol and incubated with the indicated probe (0.2 pmol) for 20 min at 41C. The incubated samples were analyzed by 4% non-denaturing polyacrylamide gels.
Immunoprecipitation analysis. The protein-DNA interaction was evaluated using the ChIP assay kit (Upstate Biotechnology) according to the manufacturer's protocol. Nuclear extracts (5 mg) as described above were incubated with the indicated probe (6 fmol) for 20 min at 41C and then fixed with formaldehyde for 10 min at 371C. The DNA-protein complex was immunoprecipitated using anti-XBP1 or anti-NF-YA (1 mg) antibody overnight at 41C and evaluated by PCR amplification using specific primers, that is, primers for catalase promoter, 5 0 -tctccccagtctcttcctatc-3 0 and 5 0 -tcaggctccaccaatcagcac-3 0 ; for its coding region, 5 0 -tcgagtggccaactaccagcgtg-3 0 and 5 0 -gtacttgtccagaagagcctggatg-3 0 . The probes were prepared by PCR amplification using pGL3-Basic CAT(À191/ þ 68), its mutant (mutation at the CCAAT box2) and MEF cDNA as templates. Sensitivity of PCR amplification was evaluated on the recovered probe DNA after incubation with nuclear extracts and fixation (input fraction). Three independent experiments were performed and similar results were obtained.
Statistical analysis. Statistical analysis was evaluated using Student's t-test (SPSS s program version 10.1; SPSS, San Rafael, CA, USA). Po0.05 was considered statistically significant.
